nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—CNR1—muscle cancer	0.519	0.844	CbGaD
Acetaminophen—PTGS2—muscle cancer	0.0959	0.156	CbGaD
Acetaminophen—CYP1A1—Dacarbazine—muscle cancer	0.0444	0.146	CbGbCtD
Acetaminophen—UGT1A1—Etoposide—muscle cancer	0.0428	0.141	CbGbCtD
Acetaminophen—CYP2E1—Dacarbazine—muscle cancer	0.0343	0.113	CbGbCtD
Acetaminophen—PTGS2—Etoposide—muscle cancer	0.0257	0.0846	CbGbCtD
Acetaminophen—PTGS1—Etoposide—muscle cancer	0.0217	0.0714	CbGbCtD
Acetaminophen—CYP1A2—Dacarbazine—muscle cancer	0.0198	0.0652	CbGbCtD
Acetaminophen—CYP2E1—Etoposide—muscle cancer	0.0168	0.0552	CbGbCtD
Acetaminophen—ABCB1—Dactinomycin—muscle cancer	0.015	0.0495	CbGbCtD
Acetaminophen—SLC22A6—Methotrexate—muscle cancer	0.0126	0.0414	CbGbCtD
Acetaminophen—CYP2C8—Etoposide—muscle cancer	0.0125	0.0412	CbGbCtD
Acetaminophen—CYP1A2—Etoposide—muscle cancer	0.00971	0.0319	CbGbCtD
Acetaminophen—ABCB1—Vincristine—muscle cancer	0.00926	0.0305	CbGbCtD
Acetaminophen—ABCB1—Etoposide—muscle cancer	0.00849	0.0279	CbGbCtD
Acetaminophen—ABCB1—Doxorubicin—muscle cancer	0.00579	0.019	CbGbCtD
Acetaminophen—ABCB1—Methotrexate—muscle cancer	0.00561	0.0184	CbGbCtD
Acetaminophen—CYP3A4—Vincristine—muscle cancer	0.00555	0.0182	CbGbCtD
Acetaminophen—CYP2D6—Doxorubicin—muscle cancer	0.00546	0.0179	CbGbCtD
Acetaminophen—CYP3A4—Etoposide—muscle cancer	0.00509	0.0167	CbGbCtD
Acetaminophen—CYP3A4—Doxorubicin—muscle cancer	0.00347	0.0114	CbGbCtD
Acetaminophen—UGT1A10—renal system—muscle cancer	0.00179	0.0659	CbGeAlD
Acetaminophen—NAT2—renal system—muscle cancer	0.00166	0.0612	CbGeAlD
Acetaminophen—SULT1A1—renal system—muscle cancer	0.00123	0.0452	CbGeAlD
Acetaminophen—TRPV1—renal system—muscle cancer	0.00108	0.0398	CbGeAlD
Acetaminophen—UGT1A6—testis—muscle cancer	0.00107	0.0396	CbGeAlD
Acetaminophen—PTGS2—hindlimb—muscle cancer	0.00105	0.0386	CbGeAlD
Acetaminophen—SULT2A1—head—muscle cancer	0.00103	0.0381	CbGeAlD
Acetaminophen—SULT1E1—vagina—muscle cancer	0.00103	0.0381	CbGeAlD
Acetaminophen—SULT2A1—testis—muscle cancer	0.000998	0.0368	CbGeAlD
Acetaminophen—SULT1A1—tendon—muscle cancer	0.000958	0.0353	CbGeAlD
Acetaminophen—SULT1E1—testis—muscle cancer	0.000921	0.034	CbGeAlD
Acetaminophen—PTGS2—appendage—muscle cancer	0.000897	0.0331	CbGeAlD
Acetaminophen—UGT1A9—renal system—muscle cancer	0.000897	0.0331	CbGeAlD
Acetaminophen—SULT1A1—vagina—muscle cancer	0.000889	0.0328	CbGeAlD
Acetaminophen—CNR1—testis—muscle cancer	0.000862	0.0318	CbGeAlD
Acetaminophen—SULT1A1—head—muscle cancer	0.000821	0.0303	CbGeAlD
Acetaminophen—SULT1A1—testis—muscle cancer	0.000793	0.0292	CbGeAlD
Acetaminophen—TRPV1—head—muscle cancer	0.000723	0.0266	CbGeAlD
Acetaminophen—TRPV1—testis—muscle cancer	0.000698	0.0257	CbGeAlD
Acetaminophen—UGT1A1—renal system—muscle cancer	0.000615	0.0227	CbGeAlD
Acetaminophen—CYP2A6—vagina—muscle cancer	0.000375	0.0138	CbGeAlD
Acetaminophen—PTGS2—embryo—muscle cancer	0.000298	0.011	CbGeAlD
Acetaminophen—CYP2C8—renal system—muscle cancer	0.000291	0.0107	CbGeAlD
Acetaminophen—CYP1A2—renal system—muscle cancer	0.000272	0.01	CbGeAlD
Acetaminophen—CYP1A1—renal system—muscle cancer	0.000268	0.0099	CbGeAlD
Acetaminophen—PTGS1—smooth muscle tissue—muscle cancer	0.000245	0.00903	CbGeAlD
Acetaminophen—CYP2E1—renal system—muscle cancer	0.000245	0.00903	CbGeAlD
Acetaminophen—CYP1A1—cardiac atrium—muscle cancer	0.00024	0.00887	CbGeAlD
Acetaminophen—PTGS1—renal system—muscle cancer	0.000236	0.0087	CbGeAlD
Acetaminophen—PTGS2—smooth muscle tissue—muscle cancer	0.000234	0.00863	CbGeAlD
Acetaminophen—PTGS2—renal system—muscle cancer	0.000225	0.00831	CbGeAlD
Acetaminophen—PTGS1—cardiac atrium—muscle cancer	0.000211	0.00779	CbGeAlD
Acetaminophen—CYP2C8—vagina—muscle cancer	0.000211	0.00777	CbGeAlD
Acetaminophen—CYP3A4—renal system—muscle cancer	0.000197	0.00726	CbGeAlD
Acetaminophen—CYP1A1—vagina—muscle cancer	0.000194	0.00717	CbGeAlD
Acetaminophen—CYP2D6—renal system—muscle cancer	0.000194	0.00715	CbGeAlD
Acetaminophen—CYP2E1—tendon—muscle cancer	0.000191	0.00705	CbGeAlD
Acetaminophen—CYP2C8—testis—muscle cancer	0.000188	0.00693	CbGeAlD
Acetaminophen—ABCB1—embryo—muscle cancer	0.000184	0.00679	CbGeAlD
Acetaminophen—PTGS1—tendon—muscle cancer	0.000184	0.00679	CbGeAlD
Acetaminophen—CYP1A1—head—muscle cancer	0.00018	0.00662	CbGeAlD
Acetaminophen—Rash maculo-papular—Doxorubicin—muscle cancer	0.000179	0.00337	CcSEcCtD
Acetaminophen—Renal failure acute—Methotrexate—muscle cancer	0.000178	0.00337	CcSEcCtD
Acetaminophen—Anorexia—Dactinomycin—muscle cancer	0.000178	0.00336	CcSEcCtD
Acetaminophen—Eye disorder—Etoposide—muscle cancer	0.000178	0.00336	CcSEcCtD
Acetaminophen—Convulsion—Vincristine—muscle cancer	0.000177	0.00335	CcSEcCtD
Acetaminophen—Flushing—Etoposide—muscle cancer	0.000177	0.00334	CcSEcCtD
Acetaminophen—Cardiac disorder—Etoposide—muscle cancer	0.000177	0.00334	CcSEcCtD
Acetaminophen—Hypertension—Vincristine—muscle cancer	0.000177	0.00333	CcSEcCtD
Acetaminophen—PTGS2—tendon—muscle cancer	0.000176	0.00649	CbGeAlD
Acetaminophen—Pulmonary oedema—Doxorubicin—muscle cancer	0.000175	0.0033	CcSEcCtD
Acetaminophen—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000175	0.0033	CcSEcCtD
Acetaminophen—Angiopathy—Etoposide—muscle cancer	0.000173	0.00326	CcSEcCtD
Acetaminophen—Immune system disorder—Etoposide—muscle cancer	0.000172	0.00325	CcSEcCtD
Acetaminophen—Mediastinal disorder—Etoposide—muscle cancer	0.000172	0.00324	CcSEcCtD
Acetaminophen—PTGS1—vagina—muscle cancer	0.000171	0.0063	CbGeAlD
Acetaminophen—Chills—Etoposide—muscle cancer	0.000171	0.00323	CcSEcCtD
Acetaminophen—PTGS2—bone marrow—muscle cancer	0.00017	0.00628	CbGeAlD
Acetaminophen—Oedema—Vincristine—muscle cancer	0.000167	0.00315	CcSEcCtD
Acetaminophen—Anaphylactic shock—Vincristine—muscle cancer	0.000167	0.00315	CcSEcCtD
Acetaminophen—CYP2E1—head—muscle cancer	0.000164	0.00604	CbGeAlD
Acetaminophen—Nervous system disorder—Vincristine—muscle cancer	0.000164	0.00309	CcSEcCtD
Acetaminophen—Thrombocytopenia—Vincristine—muscle cancer	0.000163	0.00309	CcSEcCtD
Acetaminophen—PTGS2—vagina—muscle cancer	0.000163	0.00602	CbGeAlD
Acetaminophen—Hepatic function abnormal—Doxorubicin—muscle cancer	0.000163	0.00308	CcSEcCtD
Acetaminophen—Photosensitivity—Doxorubicin—muscle cancer	0.000162	0.00307	CcSEcCtD
Acetaminophen—Decreased appetite—Dactinomycin—muscle cancer	0.000162	0.00307	CcSEcCtD
Acetaminophen—Hyperhidrosis—Vincristine—muscle cancer	0.000161	0.00305	CcSEcCtD
Acetaminophen—Fatigue—Dactinomycin—muscle cancer	0.000161	0.00304	CcSEcCtD
Acetaminophen—Muscle spasms—Etoposide—muscle cancer	0.000159	0.00301	CcSEcCtD
Acetaminophen—Anorexia—Vincristine—muscle cancer	0.000159	0.003	CcSEcCtD
Acetaminophen—Hepatic failure—Doxorubicin—muscle cancer	0.000159	0.003	CcSEcCtD
Acetaminophen—CYP2E1—testis—muscle cancer	0.000158	0.00583	CbGeAlD
Acetaminophen—PTGS1—head—muscle cancer	0.000158	0.00582	CbGeAlD
Acetaminophen—Irritability—Methotrexate—muscle cancer	0.000157	0.00297	CcSEcCtD
Acetaminophen—Hypotension—Vincristine—muscle cancer	0.000156	0.00295	CcSEcCtD
Acetaminophen—Renal failure acute—Doxorubicin—muscle cancer	0.000155	0.00292	CcSEcCtD
Acetaminophen—Feeling abnormal—Dactinomycin—muscle cancer	0.000154	0.00291	CcSEcCtD
Acetaminophen—Ill-defined disorder—Etoposide—muscle cancer	0.000154	0.0029	CcSEcCtD
Acetaminophen—Anaemia—Etoposide—muscle cancer	0.000153	0.00289	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000153	0.00289	CcSEcCtD
Acetaminophen—PTGS1—testis—muscle cancer	0.000152	0.00562	CbGeAlD
Acetaminophen—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000151	0.00286	CcSEcCtD
Acetaminophen—Insomnia—Vincristine—muscle cancer	0.000151	0.00285	CcSEcCtD
Acetaminophen—PTGS2—head—muscle cancer	0.000151	0.00556	CbGeAlD
Acetaminophen—Malaise—Etoposide—muscle cancer	0.000149	0.00282	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000148	0.0028	CcSEcCtD
Acetaminophen—Leukopenia—Etoposide—muscle cancer	0.000148	0.0028	CcSEcCtD
Acetaminophen—Abdominal pain—Dactinomycin—muscle cancer	0.000148	0.00279	CcSEcCtD
Acetaminophen—Body temperature increased—Dactinomycin—muscle cancer	0.000148	0.00279	CcSEcCtD
Acetaminophen—Decreased appetite—Vincristine—muscle cancer	0.000145	0.00274	CcSEcCtD
Acetaminophen—Cough—Etoposide—muscle cancer	0.000145	0.00273	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Vincristine—muscle cancer	0.000144	0.00272	CcSEcCtD
Acetaminophen—Fatigue—Vincristine—muscle cancer	0.000144	0.00272	CcSEcCtD
Acetaminophen—Convulsion—Etoposide—muscle cancer	0.000144	0.00271	CcSEcCtD
Acetaminophen—Hypertension—Etoposide—muscle cancer	0.000143	0.0027	CcSEcCtD
Acetaminophen—Constipation—Vincristine—muscle cancer	0.000143	0.0027	CcSEcCtD
Acetaminophen—Pain in extremity—Doxorubicin—muscle cancer	0.000143	0.00269	CcSEcCtD
Acetaminophen—Asthma—Methotrexate—muscle cancer	0.000142	0.00269	CcSEcCtD
Acetaminophen—Chest pain—Etoposide—muscle cancer	0.000141	0.00266	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00014	0.00265	CcSEcCtD
Acetaminophen—ABCB1—renal system—muscle cancer	0.000139	0.00514	CbGeAlD
Acetaminophen—Discomfort—Etoposide—muscle cancer	0.000139	0.00263	CcSEcCtD
Acetaminophen—Hypersensitivity—Dactinomycin—muscle cancer	0.000138	0.0026	CcSEcCtD
Acetaminophen—Abdominal discomfort—Methotrexate—muscle cancer	0.000137	0.00258	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Vincristine—muscle cancer	0.000136	0.00258	CcSEcCtD
Acetaminophen—Confusional state—Etoposide—muscle cancer	0.000136	0.00257	CcSEcCtD
Acetaminophen—Pancytopenia—Methotrexate—muscle cancer	0.000135	0.00255	CcSEcCtD
Acetaminophen—Anaphylactic shock—Etoposide—muscle cancer	0.000135	0.00255	CcSEcCtD
Acetaminophen—Asthenia—Dactinomycin—muscle cancer	0.000134	0.00253	CcSEcCtD
Acetaminophen—Neutropenia—Methotrexate—muscle cancer	0.000133	0.00252	CcSEcCtD
Acetaminophen—Dysuria—Methotrexate—muscle cancer	0.000133	0.00252	CcSEcCtD
Acetaminophen—Thrombocytopenia—Etoposide—muscle cancer	0.000132	0.0025	CcSEcCtD
Acetaminophen—Tachycardia—Etoposide—muscle cancer	0.000132	0.00249	CcSEcCtD
Acetaminophen—Abdominal pain—Vincristine—muscle cancer	0.000132	0.00249	CcSEcCtD
Acetaminophen—Body temperature increased—Vincristine—muscle cancer	0.000132	0.00249	CcSEcCtD
Acetaminophen—Skin disorder—Etoposide—muscle cancer	0.000131	0.00248	CcSEcCtD
Acetaminophen—Hyperhidrosis—Etoposide—muscle cancer	0.000131	0.00247	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Methotrexate—muscle cancer	0.00013	0.00246	CcSEcCtD
Acetaminophen—Hypokalaemia—Doxorubicin—muscle cancer	0.00013	0.00245	CcSEcCtD
Acetaminophen—CYP2D6—head—muscle cancer	0.00013	0.00478	CbGeAlD
Acetaminophen—Anorexia—Etoposide—muscle cancer	0.000129	0.00243	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000128	0.00243	CcSEcCtD
Acetaminophen—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000128	0.00243	CcSEcCtD
Acetaminophen—Diarrhoea—Dactinomycin—muscle cancer	0.000128	0.00241	CcSEcCtD
Acetaminophen—Drowsiness—Methotrexate—muscle cancer	0.000127	0.0024	CcSEcCtD
Acetaminophen—Hypotension—Etoposide—muscle cancer	0.000126	0.00239	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000126	0.00238	CcSEcCtD
Acetaminophen—Muscular weakness—Doxorubicin—muscle cancer	0.000126	0.00238	CcSEcCtD
Acetaminophen—CYP2D6—testis—muscle cancer	0.000125	0.00462	CbGeAlD
Acetaminophen—Abdominal distension—Doxorubicin—muscle cancer	0.000124	0.00234	CcSEcCtD
Acetaminophen—Asthma—Doxorubicin—muscle cancer	0.000123	0.00233	CcSEcCtD
Acetaminophen—Hypersensitivity—Vincristine—muscle cancer	0.000123	0.00232	CcSEcCtD
Acetaminophen—Sweating—Methotrexate—muscle cancer	0.000122	0.0023	CcSEcCtD
Acetaminophen—Dyspnoea—Etoposide—muscle cancer	0.000121	0.00228	CcSEcCtD
Acetaminophen—Somnolence—Etoposide—muscle cancer	0.00012	0.00227	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Methotrexate—muscle cancer	0.00012	0.00227	CcSEcCtD
Acetaminophen—Asthenia—Vincristine—muscle cancer	0.00012	0.00226	CcSEcCtD
Acetaminophen—Vomiting—Dactinomycin—muscle cancer	0.000119	0.00224	CcSEcCtD
Acetaminophen—Agranulocytosis—Methotrexate—muscle cancer	0.000118	0.00224	CcSEcCtD
Acetaminophen—Rash—Dactinomycin—muscle cancer	0.000118	0.00222	CcSEcCtD
Acetaminophen—Decreased appetite—Etoposide—muscle cancer	0.000118	0.00222	CcSEcCtD
Acetaminophen—Pancytopenia—Doxorubicin—muscle cancer	0.000117	0.00221	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Etoposide—muscle cancer	0.000117	0.0022	CcSEcCtD
Acetaminophen—Fatigue—Etoposide—muscle cancer	0.000117	0.0022	CcSEcCtD
Acetaminophen—Constipation—Etoposide—muscle cancer	0.000116	0.00218	CcSEcCtD
Acetaminophen—Dysuria—Doxorubicin—muscle cancer	0.000115	0.00218	CcSEcCtD
Acetaminophen—Neutropenia—Doxorubicin—muscle cancer	0.000115	0.00218	CcSEcCtD
Acetaminophen—Haemoglobin—Methotrexate—muscle cancer	0.000115	0.00216	CcSEcCtD
Acetaminophen—Diarrhoea—Vincristine—muscle cancer	0.000114	0.00216	CcSEcCtD
Acetaminophen—Haemorrhage—Methotrexate—muscle cancer	0.000114	0.00215	CcSEcCtD
Acetaminophen—Hepatitis—Methotrexate—muscle cancer	0.000114	0.00215	CcSEcCtD
Acetaminophen—Urinary tract disorder—Methotrexate—muscle cancer	0.000113	0.00213	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000113	0.00213	CcSEcCtD
Acetaminophen—Urethral disorder—Methotrexate—muscle cancer	0.000112	0.00211	CcSEcCtD
Acetaminophen—Feeling abnormal—Etoposide—muscle cancer	0.000111	0.0021	CcSEcCtD
Acetaminophen—Hyperglycaemia—Doxorubicin—muscle cancer	0.000111	0.0021	CcSEcCtD
Acetaminophen—Nausea—Dactinomycin—muscle cancer	0.000111	0.0021	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Etoposide—muscle cancer	0.000111	0.00209	CcSEcCtD
Acetaminophen—Dizziness—Vincristine—muscle cancer	0.00011	0.00208	CcSEcCtD
Acetaminophen—Drowsiness—Doxorubicin—muscle cancer	0.00011	0.00208	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000109	0.00206	CcSEcCtD
Acetaminophen—Erythema multiforme—Methotrexate—muscle cancer	0.000108	0.00204	CcSEcCtD
Acetaminophen—Urticaria—Etoposide—muscle cancer	0.000107	0.00203	CcSEcCtD
Acetaminophen—Body temperature increased—Etoposide—muscle cancer	0.000107	0.00202	CcSEcCtD
Acetaminophen—Abdominal pain—Etoposide—muscle cancer	0.000107	0.00202	CcSEcCtD
Acetaminophen—Eye disorder—Methotrexate—muscle cancer	0.000107	0.00201	CcSEcCtD
Acetaminophen—Vomiting—Vincristine—muscle cancer	0.000106	0.002	CcSEcCtD
Acetaminophen—Cardiac disorder—Methotrexate—muscle cancer	0.000106	0.002	CcSEcCtD
Acetaminophen—ABCB1—bone marrow—muscle cancer	0.000105	0.00389	CbGeAlD
Acetaminophen—Sweating—Doxorubicin—muscle cancer	0.000105	0.00199	CcSEcCtD
Acetaminophen—Rash—Vincristine—muscle cancer	0.000105	0.00199	CcSEcCtD
Acetaminophen—Dermatitis—Vincristine—muscle cancer	0.000105	0.00199	CcSEcCtD
Acetaminophen—Headache—Vincristine—muscle cancer	0.000105	0.00197	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000104	0.00196	CcSEcCtD
Acetaminophen—Angiopathy—Methotrexate—muscle cancer	0.000103	0.00195	CcSEcCtD
Acetaminophen—Immune system disorder—Methotrexate—muscle cancer	0.000103	0.00194	CcSEcCtD
Acetaminophen—Mediastinal disorder—Methotrexate—muscle cancer	0.000103	0.00194	CcSEcCtD
Acetaminophen—Agranulocytosis—Doxorubicin—muscle cancer	0.000103	0.00194	CcSEcCtD
Acetaminophen—Chills—Methotrexate—muscle cancer	0.000102	0.00193	CcSEcCtD
Acetaminophen—ABCB1—vagina—muscle cancer	0.000101	0.00372	CbGeAlD
Acetaminophen—Mental disorder—Methotrexate—muscle cancer	9.99e-05	0.00189	CcSEcCtD
Acetaminophen—Hypersensitivity—Etoposide—muscle cancer	9.96e-05	0.00188	CcSEcCtD
Acetaminophen—Malnutrition—Methotrexate—muscle cancer	9.92e-05	0.00187	CcSEcCtD
Acetaminophen—Erythema—Methotrexate—muscle cancer	9.92e-05	0.00187	CcSEcCtD
Acetaminophen—Haemoglobin—Doxorubicin—muscle cancer	9.92e-05	0.00187	CcSEcCtD
Acetaminophen—Nausea—Vincristine—muscle cancer	9.91e-05	0.00187	CcSEcCtD
Acetaminophen—Haemorrhage—Doxorubicin—muscle cancer	9.87e-05	0.00186	CcSEcCtD
Acetaminophen—Hepatitis—Doxorubicin—muscle cancer	9.87e-05	0.00186	CcSEcCtD
Acetaminophen—Urinary tract disorder—Doxorubicin—muscle cancer	9.75e-05	0.00184	CcSEcCtD
Acetaminophen—Oedema peripheral—Doxorubicin—muscle cancer	9.72e-05	0.00184	CcSEcCtD
Acetaminophen—Asthenia—Etoposide—muscle cancer	9.7e-05	0.00183	CcSEcCtD
Acetaminophen—Connective tissue disorder—Doxorubicin—muscle cancer	9.7e-05	0.00183	CcSEcCtD
Acetaminophen—Urethral disorder—Doxorubicin—muscle cancer	9.68e-05	0.00183	CcSEcCtD
Acetaminophen—Pruritus—Etoposide—muscle cancer	9.57e-05	0.00181	CcSEcCtD
Acetaminophen—SULT2A1—E2F transcription factor network—TFE3—muscle cancer	9.43e-05	0.091	CbGpPWpGaD
Acetaminophen—Vision blurred—Methotrexate—muscle cancer	9.35e-05	0.00177	CcSEcCtD
Acetaminophen—Erythema multiforme—Doxorubicin—muscle cancer	9.33e-05	0.00176	CcSEcCtD
Acetaminophen—ABCB1—head—muscle cancer	9.33e-05	0.00344	CbGeAlD
Acetaminophen—Diarrhoea—Etoposide—muscle cancer	9.25e-05	0.00175	CcSEcCtD
Acetaminophen—Eye disorder—Doxorubicin—muscle cancer	9.22e-05	0.00174	CcSEcCtD
Acetaminophen—Ill-defined disorder—Methotrexate—muscle cancer	9.21e-05	0.00174	CcSEcCtD
Acetaminophen—Anaemia—Methotrexate—muscle cancer	9.17e-05	0.00173	CcSEcCtD
Acetaminophen—Flushing—Doxorubicin—muscle cancer	9.16e-05	0.00173	CcSEcCtD
Acetaminophen—Cardiac disorder—Doxorubicin—muscle cancer	9.16e-05	0.00173	CcSEcCtD
Acetaminophen—ABCB1—testis—muscle cancer	9.01e-05	0.00332	CbGeAlD
Acetaminophen—Angiopathy—Doxorubicin—muscle cancer	8.95e-05	0.00169	CcSEcCtD
Acetaminophen—Malaise—Methotrexate—muscle cancer	8.95e-05	0.00169	CcSEcCtD
Acetaminophen—Dizziness—Etoposide—muscle cancer	8.94e-05	0.00169	CcSEcCtD
Acetaminophen—Immune system disorder—Doxorubicin—muscle cancer	8.92e-05	0.00168	CcSEcCtD
Acetaminophen—Mediastinal disorder—Doxorubicin—muscle cancer	8.9e-05	0.00168	CcSEcCtD
Acetaminophen—Leukopenia—Methotrexate—muscle cancer	8.88e-05	0.00168	CcSEcCtD
Acetaminophen—Chills—Doxorubicin—muscle cancer	8.86e-05	0.00167	CcSEcCtD
Acetaminophen—Cough—Methotrexate—muscle cancer	8.66e-05	0.00164	CcSEcCtD
Acetaminophen—Mental disorder—Doxorubicin—muscle cancer	8.65e-05	0.00163	CcSEcCtD
Acetaminophen—Convulsion—Methotrexate—muscle cancer	8.6e-05	0.00162	CcSEcCtD
Acetaminophen—Vomiting—Etoposide—muscle cancer	8.6e-05	0.00162	CcSEcCtD
Acetaminophen—Erythema—Doxorubicin—muscle cancer	8.59e-05	0.00162	CcSEcCtD
Acetaminophen—Malnutrition—Doxorubicin—muscle cancer	8.59e-05	0.00162	CcSEcCtD
Acetaminophen—Rash—Etoposide—muscle cancer	8.52e-05	0.00161	CcSEcCtD
Acetaminophen—Dermatitis—Etoposide—muscle cancer	8.52e-05	0.00161	CcSEcCtD
Acetaminophen—Headache—Etoposide—muscle cancer	8.47e-05	0.0016	CcSEcCtD
Acetaminophen—Chest pain—Methotrexate—muscle cancer	8.45e-05	0.0016	CcSEcCtD
Acetaminophen—Tension—Doxorubicin—muscle cancer	8.43e-05	0.00159	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	8.39e-05	0.00158	CcSEcCtD
Acetaminophen—Discomfort—Methotrexate—muscle cancer	8.35e-05	0.00158	CcSEcCtD
Acetaminophen—Nervousness—Doxorubicin—muscle cancer	8.34e-05	0.00158	CcSEcCtD
Acetaminophen—Muscle spasms—Doxorubicin—muscle cancer	8.26e-05	0.00156	CcSEcCtD
Acetaminophen—Confusional state—Methotrexate—muscle cancer	8.17e-05	0.00154	CcSEcCtD
Acetaminophen—Anaphylactic shock—Methotrexate—muscle cancer	8.1e-05	0.00153	CcSEcCtD
Acetaminophen—Vision blurred—Doxorubicin—muscle cancer	8.1e-05	0.00153	CcSEcCtD
Acetaminophen—Nausea—Etoposide—muscle cancer	8.03e-05	0.00152	CcSEcCtD
Acetaminophen—Ill-defined disorder—Doxorubicin—muscle cancer	7.97e-05	0.00151	CcSEcCtD
Acetaminophen—Nervous system disorder—Methotrexate—muscle cancer	7.94e-05	0.0015	CcSEcCtD
Acetaminophen—Anaemia—Doxorubicin—muscle cancer	7.94e-05	0.0015	CcSEcCtD
Acetaminophen—Thrombocytopenia—Methotrexate—muscle cancer	7.93e-05	0.0015	CcSEcCtD
Acetaminophen—Agitation—Doxorubicin—muscle cancer	7.9e-05	0.00149	CcSEcCtD
Acetaminophen—Skin disorder—Methotrexate—muscle cancer	7.87e-05	0.00149	CcSEcCtD
Acetaminophen—Hyperhidrosis—Methotrexate—muscle cancer	7.83e-05	0.00148	CcSEcCtD
Acetaminophen—Malaise—Doxorubicin—muscle cancer	7.75e-05	0.00146	CcSEcCtD
Acetaminophen—Anorexia—Methotrexate—muscle cancer	7.72e-05	0.00146	CcSEcCtD
Acetaminophen—Leukopenia—Doxorubicin—muscle cancer	7.69e-05	0.00145	CcSEcCtD
Acetaminophen—Palpitations—Doxorubicin—muscle cancer	7.59e-05	0.00143	CcSEcCtD
Acetaminophen—Hypotension—Methotrexate—muscle cancer	7.57e-05	0.00143	CcSEcCtD
Acetaminophen—Cough—Doxorubicin—muscle cancer	7.5e-05	0.00142	CcSEcCtD
Acetaminophen—Convulsion—Doxorubicin—muscle cancer	7.44e-05	0.00141	CcSEcCtD
Acetaminophen—Hypertension—Doxorubicin—muscle cancer	7.42e-05	0.0014	CcSEcCtD
Acetaminophen—Insomnia—Methotrexate—muscle cancer	7.32e-05	0.00138	CcSEcCtD
Acetaminophen—Chest pain—Doxorubicin—muscle cancer	7.31e-05	0.00138	CcSEcCtD
Acetaminophen—Anxiety—Doxorubicin—muscle cancer	7.29e-05	0.00138	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	7.26e-05	0.00137	CcSEcCtD
Acetaminophen—Discomfort—Doxorubicin—muscle cancer	7.23e-05	0.00137	CcSEcCtD
Acetaminophen—Dyspnoea—Methotrexate—muscle cancer	7.22e-05	0.00136	CcSEcCtD
Acetaminophen—Somnolence—Methotrexate—muscle cancer	7.2e-05	0.00136	CcSEcCtD
Acetaminophen—Dry mouth—Doxorubicin—muscle cancer	7.15e-05	0.00135	CcSEcCtD
Acetaminophen—Dyspepsia—Methotrexate—muscle cancer	7.13e-05	0.00135	CcSEcCtD
Acetaminophen—Confusional state—Doxorubicin—muscle cancer	7.07e-05	0.00134	CcSEcCtD
Acetaminophen—Decreased appetite—Methotrexate—muscle cancer	7.04e-05	0.00133	CcSEcCtD
Acetaminophen—Oedema—Doxorubicin—muscle cancer	7.01e-05	0.00132	CcSEcCtD
Acetaminophen—Anaphylactic shock—Doxorubicin—muscle cancer	7.01e-05	0.00132	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Methotrexate—muscle cancer	6.99e-05	0.00132	CcSEcCtD
Acetaminophen—Fatigue—Methotrexate—muscle cancer	6.98e-05	0.00132	CcSEcCtD
Acetaminophen—Shock—Doxorubicin—muscle cancer	6.9e-05	0.0013	CcSEcCtD
Acetaminophen—Nervous system disorder—Doxorubicin—muscle cancer	6.88e-05	0.0013	CcSEcCtD
Acetaminophen—Thrombocytopenia—Doxorubicin—muscle cancer	6.87e-05	0.0013	CcSEcCtD
Acetaminophen—Tachycardia—Doxorubicin—muscle cancer	6.84e-05	0.00129	CcSEcCtD
Acetaminophen—Skin disorder—Doxorubicin—muscle cancer	6.81e-05	0.00129	CcSEcCtD
Acetaminophen—Hyperhidrosis—Doxorubicin—muscle cancer	6.78e-05	0.00128	CcSEcCtD
Acetaminophen—Anorexia—Doxorubicin—muscle cancer	6.68e-05	0.00126	CcSEcCtD
Acetaminophen—Feeling abnormal—Methotrexate—muscle cancer	6.67e-05	0.00126	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Methotrexate—muscle cancer	6.62e-05	0.00125	CcSEcCtD
Acetaminophen—Hypotension—Doxorubicin—muscle cancer	6.55e-05	0.00124	CcSEcCtD
Acetaminophen—Urticaria—Methotrexate—muscle cancer	6.43e-05	0.00122	CcSEcCtD
Acetaminophen—Abdominal pain—Methotrexate—muscle cancer	6.4e-05	0.00121	CcSEcCtD
Acetaminophen—Body temperature increased—Methotrexate—muscle cancer	6.4e-05	0.00121	CcSEcCtD
Acetaminophen—SULT2A1—E2F transcription factor network—TP73—muscle cancer	6.37e-05	0.0614	CbGpPWpGaD
Acetaminophen—Insomnia—Doxorubicin—muscle cancer	6.34e-05	0.0012	CcSEcCtD
Acetaminophen—Dyspnoea—Doxorubicin—muscle cancer	6.25e-05	0.00118	CcSEcCtD
Acetaminophen—Somnolence—Doxorubicin—muscle cancer	6.23e-05	0.00118	CcSEcCtD
Acetaminophen—Dyspepsia—Doxorubicin—muscle cancer	6.17e-05	0.00117	CcSEcCtD
Acetaminophen—Decreased appetite—Doxorubicin—muscle cancer	6.1e-05	0.00115	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Doxorubicin—muscle cancer	6.05e-05	0.00114	CcSEcCtD
Acetaminophen—Fatigue—Doxorubicin—muscle cancer	6.05e-05	0.00114	CcSEcCtD
Acetaminophen—Constipation—Doxorubicin—muscle cancer	6e-05	0.00113	CcSEcCtD
Acetaminophen—Hypersensitivity—Methotrexate—muscle cancer	5.97e-05	0.00113	CcSEcCtD
Acetaminophen—SULT1A1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	5.86e-05	0.0565	CbGpPWpGaD
Acetaminophen—Asthenia—Methotrexate—muscle cancer	5.81e-05	0.0011	CcSEcCtD
Acetaminophen—Feeling abnormal—Doxorubicin—muscle cancer	5.78e-05	0.00109	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Doxorubicin—muscle cancer	5.73e-05	0.00108	CcSEcCtD
Acetaminophen—Pruritus—Methotrexate—muscle cancer	5.73e-05	0.00108	CcSEcCtD
Acetaminophen—Urticaria—Doxorubicin—muscle cancer	5.57e-05	0.00105	CcSEcCtD
Acetaminophen—Abdominal pain—Doxorubicin—muscle cancer	5.54e-05	0.00105	CcSEcCtD
Acetaminophen—Body temperature increased—Doxorubicin—muscle cancer	5.54e-05	0.00105	CcSEcCtD
Acetaminophen—Diarrhoea—Methotrexate—muscle cancer	5.54e-05	0.00105	CcSEcCtD
Acetaminophen—Dizziness—Methotrexate—muscle cancer	5.36e-05	0.00101	CcSEcCtD
Acetaminophen—CNR1—BDNF signaling pathway—KIDINS220—muscle cancer	5.33e-05	0.0514	CbGpPWpGaD
Acetaminophen—Hypersensitivity—Doxorubicin—muscle cancer	5.17e-05	0.000976	CcSEcCtD
Acetaminophen—Vomiting—Methotrexate—muscle cancer	5.15e-05	0.000973	CcSEcCtD
Acetaminophen—Rash—Methotrexate—muscle cancer	5.11e-05	0.000964	CcSEcCtD
Acetaminophen—Dermatitis—Methotrexate—muscle cancer	5.1e-05	0.000964	CcSEcCtD
Acetaminophen—Headache—Methotrexate—muscle cancer	5.07e-05	0.000958	CcSEcCtD
Acetaminophen—SULT2A1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	5.04e-05	0.0486	CbGpPWpGaD
Acetaminophen—Asthenia—Doxorubicin—muscle cancer	5.03e-05	0.00095	CcSEcCtD
Acetaminophen—Pruritus—Doxorubicin—muscle cancer	4.96e-05	0.000937	CcSEcCtD
Acetaminophen—Nausea—Methotrexate—muscle cancer	4.81e-05	0.000909	CcSEcCtD
Acetaminophen—Diarrhoea—Doxorubicin—muscle cancer	4.8e-05	0.000906	CcSEcCtD
Acetaminophen—Dizziness—Doxorubicin—muscle cancer	4.64e-05	0.000876	CcSEcCtD
Acetaminophen—Vomiting—Doxorubicin—muscle cancer	4.46e-05	0.000842	CcSEcCtD
Acetaminophen—Rash—Doxorubicin—muscle cancer	4.42e-05	0.000835	CcSEcCtD
Acetaminophen—Dermatitis—Doxorubicin—muscle cancer	4.42e-05	0.000834	CcSEcCtD
Acetaminophen—Headache—Doxorubicin—muscle cancer	4.39e-05	0.00083	CcSEcCtD
Acetaminophen—Nausea—Doxorubicin—muscle cancer	4.17e-05	0.000787	CcSEcCtD
Acetaminophen—UGT1A6—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	3.77e-05	0.0364	CbGpPWpGaD
Acetaminophen—SULT2A1—PPARA activates gene expression—MED12—muscle cancer	3.42e-05	0.033	CbGpPWpGaD
Acetaminophen—SULT2A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—muscle cancer	3.35e-05	0.0323	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—MYF6—muscle cancer	2.5e-05	0.0242	CbGpPWpGaD
Acetaminophen—SULT2A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	2.31e-05	0.0223	CbGpPWpGaD
Acetaminophen—UGT1A1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	1.67e-05	0.0161	CbGpPWpGaD
Acetaminophen—UGT1A9—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	1.67e-05	0.0161	CbGpPWpGaD
Acetaminophen—SULT2A1—E2F transcription factor network—CDKN2A—muscle cancer	1.61e-05	0.0156	CbGpPWpGaD
Acetaminophen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—muscle cancer	1.53e-05	0.0148	CbGpPWpGaD
Acetaminophen—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—muscle cancer	1.3e-05	0.0125	CbGpPWpGaD
Acetaminophen—CYP2A6—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	1.29e-05	0.0124	CbGpPWpGaD
Acetaminophen—PTGS1—Overview of nanoparticle effects—PTGS2—muscle cancer	1.2e-05	0.0116	CbGpPWpGaD
Acetaminophen—UGT1A9—PPARA activates gene expression—MED12—muscle cancer	1.14e-05	0.011	CbGpPWpGaD
Acetaminophen—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—muscle cancer	1.11e-05	0.0107	CbGpPWpGaD
Acetaminophen—CYP1A1—Melatonin metabolism and effects—FOXO1—muscle cancer	1.04e-05	0.01	CbGpPWpGaD
Acetaminophen—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—muscle cancer	1.02e-05	0.00988	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—CD34—muscle cancer	9.97e-06	0.00962	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—MYOD1—muscle cancer	9.97e-06	0.00962	CbGpPWpGaD
Acetaminophen—PTGS1—Eicosanoid Synthesis—PTGS2—muscle cancer	9.94e-06	0.00959	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—FH—muscle cancer	9.55e-06	0.00922	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	9.19e-06	0.00886	CbGpPWpGaD
Acetaminophen—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—muscle cancer	8.59e-06	0.00829	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—PTCH1—muscle cancer	8.59e-06	0.00828	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—FH—muscle cancer	8.41e-06	0.00811	CbGpPWpGaD
Acetaminophen—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—muscle cancer	8.31e-06	0.00802	CbGpPWpGaD
Acetaminophen—CYP2D6—Melatonin metabolism and effects—FOXO1—muscle cancer	7.83e-06	0.00755	CbGpPWpGaD
Acetaminophen—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	7.68e-06	0.00741	CbGpPWpGaD
Acetaminophen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	7.66e-06	0.00739	CbGpPWpGaD
Acetaminophen—PTGS2—S1P1 pathway—VEGFA—muscle cancer	7.49e-06	0.00723	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—FH—muscle cancer	7.24e-06	0.00698	CbGpPWpGaD
Acetaminophen—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	7.17e-06	0.00692	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—FH—muscle cancer	6.91e-06	0.00666	CbGpPWpGaD
Acetaminophen—CYP1A2—Melatonin metabolism and effects—FOXO1—muscle cancer	6.63e-06	0.0064	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—KIDINS220—muscle cancer	6.61e-06	0.00638	CbGpPWpGaD
Acetaminophen—CYP1A1—PPARA activates gene expression—MED12—muscle cancer	6.52e-06	0.00629	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—FH—muscle cancer	6.49e-06	0.00626	CbGpPWpGaD
Acetaminophen—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—muscle cancer	6.38e-06	0.00616	CbGpPWpGaD
Acetaminophen—PTGS1—Arachidonic acid metabolism—PTGS2—muscle cancer	5.52e-06	0.00533	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—FH—muscle cancer	5.42e-06	0.00523	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—MED12—muscle cancer	5.4e-06	0.00521	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—ENO2—muscle cancer	4.92e-06	0.00475	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	4.8e-06	0.00463	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—MED12—muscle cancer	4.75e-06	0.00458	CbGpPWpGaD
Acetaminophen—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	4.73e-06	0.00456	CbGpPWpGaD
Acetaminophen—CYP2E1—Tryptophan metabolism—MDM2—muscle cancer	4.58e-06	0.00442	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—PTCH1—muscle cancer	4.41e-06	0.00425	CbGpPWpGaD
Acetaminophen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	4.4e-06	0.00424	CbGpPWpGaD
Acetaminophen—CYP2A6—Fluoropyrimidine Activity—TP53—muscle cancer	4.33e-06	0.00418	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—ENO2—muscle cancer	4.33e-06	0.00418	CbGpPWpGaD
Acetaminophen—CYP1A1—Tryptophan metabolism—MDM2—muscle cancer	4.32e-06	0.00416	CbGpPWpGaD
Acetaminophen—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	4.16e-06	0.00401	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	4.16e-06	0.00401	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—MED12—muscle cancer	4.09e-06	0.00395	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—MED12—muscle cancer	3.9e-06	0.00377	CbGpPWpGaD
Acetaminophen—CYP1A1—Arachidonic acid metabolism—PTGS2—muscle cancer	3.89e-06	0.00375	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—KIT—muscle cancer	3.81e-06	0.00368	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—ENO2—muscle cancer	3.73e-06	0.0036	CbGpPWpGaD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	3.69e-06	0.00356	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—MED12—muscle cancer	3.67e-06	0.00354	CbGpPWpGaD
Acetaminophen—CYP2C8—Arachidonic acid metabolism—PTGS2—muscle cancer	3.57e-06	0.00344	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—ENO2—muscle cancer	3.56e-06	0.00343	CbGpPWpGaD
Acetaminophen—PTGS1—Selenium Micronutrient Network—PTGS2—muscle cancer	3.51e-06	0.00339	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	3.51e-06	0.00339	CbGpPWpGaD
Acetaminophen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—muscle cancer	3.47e-06	0.00335	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	3.41e-06	0.00329	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—ENO2—muscle cancer	3.35e-06	0.00323	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	3.28e-06	0.00316	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—CDKN2A—muscle cancer	3.1e-06	0.00299	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—MED12—muscle cancer	3.06e-06	0.00295	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.05e-06	0.00294	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.92e-06	0.00281	CbGpPWpGaD
Acetaminophen—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	2.9e-06	0.0028	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—ENO2—muscle cancer	2.79e-06	0.00269	CbGpPWpGaD
Acetaminophen—CYP1A2—Tryptophan metabolism—MDM2—muscle cancer	2.75e-06	0.00265	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	2.65e-06	0.00256	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—PTCH1—muscle cancer	2.6e-06	0.00251	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	2.49e-06	0.0024	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.49e-06	0.0024	CbGpPWpGaD
Acetaminophen—CYP1A2—Arachidonic acid metabolism—PTGS2—muscle cancer	2.48e-06	0.00239	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—FH—muscle cancer	2.4e-06	0.00232	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—FH—muscle cancer	2.4e-06	0.00232	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—FOXO4—muscle cancer	2.24e-06	0.00216	CbGpPWpGaD
Acetaminophen—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	2.12e-06	0.00205	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	2.09e-06	0.00202	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.97e-06	0.0019	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	1.96e-06	0.00189	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—FH—muscle cancer	1.96e-06	0.00189	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—FH—muscle cancer	1.85e-06	0.00179	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—IGF2—muscle cancer	1.8e-06	0.00173	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.75e-06	0.00169	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—PTGS2—muscle cancer	1.71e-06	0.00165	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—VEGFA—muscle cancer	1.7e-06	0.00164	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—FOXO1—muscle cancer	1.65e-06	0.00159	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.61e-06	0.00155	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	1.56e-06	0.0015	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—FH—muscle cancer	1.56e-06	0.0015	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—PTGS2—muscle cancer	1.51e-06	0.00146	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—FH—muscle cancer	1.46e-06	0.00141	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—FH—muscle cancer	1.38e-06	0.00133	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—MED12—muscle cancer	1.36e-06	0.00131	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—MED12—muscle cancer	1.36e-06	0.00131	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—TP53—muscle cancer	1.31e-06	0.00127	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.31e-06	0.00126	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—PTGS2—muscle cancer	1.3e-06	0.00125	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—FH—muscle cancer	1.27e-06	0.00122	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—KIT—muscle cancer	1.26e-06	0.00122	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—PTGS2—muscle cancer	1.24e-06	0.0012	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—ENO2—muscle cancer	1.24e-06	0.00119	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—ENO2—muscle cancer	1.24e-06	0.00119	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	1.18e-06	0.00114	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—PTGS2—muscle cancer	1.17e-06	0.00112	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.12e-06	0.00108	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—MED12—muscle cancer	1.11e-06	0.00107	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	1.1e-06	0.00106	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—FH—muscle cancer	1.1e-06	0.00106	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	1.06e-06	0.00103	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—MED12—muscle cancer	1.05e-06	0.00101	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—FH—muscle cancer	1.04e-06	0.001	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—FH—muscle cancer	1.03e-06	0.000994	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—ENO2—muscle cancer	1.01e-06	0.000974	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—MDM2—muscle cancer	9.92e-07	0.000957	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—PTGS2—muscle cancer	9.73e-07	0.000938	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	9.68e-07	0.000934	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—ENO2—muscle cancer	9.57e-07	0.000923	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—ENO2—muscle cancer	9.54e-07	0.000921	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	8.93e-07	0.000862	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—FH—muscle cancer	8.8e-07	0.000849	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—MED12—muscle cancer	8.79e-07	0.000848	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—HMGA1—muscle cancer	8.7e-07	0.000839	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	8.38e-07	0.000808	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—MED12—muscle cancer	8.27e-07	0.000798	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—ENO2—muscle cancer	8.01e-07	0.000773	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	7.89e-07	0.000762	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—MED12—muscle cancer	7.8e-07	0.000753	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—FOXO4—muscle cancer	7.8e-07	0.000752	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—ENO2—muscle cancer	7.54e-07	0.000728	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—VEGFA—muscle cancer	7.53e-07	0.000727	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—MED12—muscle cancer	7.15e-07	0.00069	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—ENO2—muscle cancer	7.11e-07	0.000686	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—FH—muscle cancer	6.79e-07	0.000655	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—ENO2—muscle cancer	6.52e-07	0.000629	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	6.33e-07	0.000611	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—MED12—muscle cancer	6.23e-07	0.000601	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—MED12—muscle cancer	5.87e-07	0.000566	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—MED12—muscle cancer	5.82e-07	0.000561	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—FOXO1—muscle cancer	5.76e-07	0.000556	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TP53—muscle cancer	5.69e-07	0.000549	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—ENO2—muscle cancer	5.68e-07	0.000548	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	5.56e-07	0.000537	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—ENO2—muscle cancer	5.35e-07	0.000516	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—ENO2—muscle cancer	5.31e-07	0.000512	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	5.1e-07	0.000492	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—MED12—muscle cancer	4.97e-07	0.00048	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—ENO2—muscle cancer	4.53e-07	0.000437	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—KIT—muscle cancer	4.39e-07	0.000423	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PTGS2—muscle cancer	4.31e-07	0.000416	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PTGS2—muscle cancer	4.31e-07	0.000416	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.15e-07	0.0004	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—MED12—muscle cancer	3.84e-07	0.00037	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.55e-07	0.000342	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PTGS2—muscle cancer	3.52e-07	0.000339	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ENO2—muscle cancer	3.5e-07	0.000338	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MDM2—muscle cancer	3.46e-07	0.000333	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PTGS2—muscle cancer	3.32e-07	0.000321	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PTGS2—muscle cancer	2.63e-07	0.000253	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PTGS2—muscle cancer	2.48e-07	0.000239	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PTGS2—muscle cancer	2.27e-07	0.000219	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PTGS2—muscle cancer	1.98e-07	0.000191	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PTGS2—muscle cancer	1.86e-07	0.00018	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PTGS2—muscle cancer	1.85e-07	0.000178	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PTGS2—muscle cancer	1.58e-07	0.000152	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PTGS2—muscle cancer	1.22e-07	0.000118	CbGpPWpGaD
